Table 2. Comparison of metabolic parameters measured in rats with aging or PPARγ agonist treatment.
LETO rats | OLETF rats | ||||
---|---|---|---|---|---|
21 weeks (n = 4) | 21 weeks (n = 8) | 31 weeks (n = 8) | 43 weeks (n = 5) | 21 weeks PPARγ agonist (n = 8) | |
Body weight (g) | 463.3±14.7 * | 586.6±11.0 | 614.2±19.2 | 620.0±40.0 | 608.9±38.3 |
Subcutaneous fat (% body weight) | 0.7±0.1 * | 2.6±0.7 | 4.8±0.3* | 4.7±0.8* | 3.2±0.3 |
Visceral fat (% body weight) | 0.8±0.1 * | 3.3±0.5 | 11.0±1.2* | 12.9 ±1.2* | 2.4±0.5* |
V/S ratio | 1.1±0.1 * | 1.3±0.1 | 2.3±0.1 * | 2.8±0.4* | 0.8±0.1 * |
Glucose (mmol/l) | 7.1±0.7* | 11.6±0.4 | 12.1±0.3 | 16.9±0.1* | 9.8±0.5 * |
Insulin (ng/ml) | 155.8±68.3* | 511.8±75.7 | 566.0±356.6 | 708.6±383.4* | 409.9±20.1* |
Free fatty acid (mmol/l) | 524.0±90.6 * | 944.1±62.5 | 958.7±30.2 | 1053.3±51.5* | 517.8±52.8 * |
Triglyceride (mmol/l) | 0.2±0.0* | 1.6±0.3 | 2.3±0.6 | 2.0±0.2 | 0.3±0.0* |
Data are summarized in mean ± SEM.
*P<0.05, compared with OLETF rats at 21 weeks.